Abstract
Introduction: People with rare diseases have difficulty accessing high quality information about their conditions, which impedes their ability to be engaged patients. Federal agencies such as the National Institutes of Health (NIH) have created websites to disseminate disease-related information. This study explored how people with a rare disease–Alpha-1 Antitrypsin Deficiency (AATD)–evaluated the NIH's website on AATD and how participants’ evaluation, genetic determinism, and spirituality predicted their intentions to share the website with others. Method: Participants (N = 153) living with AATD made comments about the NIH's website on the disease, and completed a survey about their perceptions of the information, individual characteristics, and intentions to share the NIH website. Results: Qualitative analyses highlighted that participants wanted to access to more complete, high quality, and interesting information on AATD on a more user-friendly website. Quantitative analyses showed that participants were more likely to share the website if they judged the information as higher quality and more interesting, with a range of such responses appearing in relation to the same website, making it evident that the meaning of quality and interest varies. Participants with severe deficiency perceived the information as lower quality and less interesting than participants with mild deficiency. Participants with stronger genetic determinism beliefs and spirituality were more likely to share the NIH's website. Conclusions: We discuss how federal agencies can craft messages that assist people with rare diseases in learning more about their conditions and dealing with the burden of sharing high quality information with providers and the public.
Original language | English |
---|---|
Pages (from-to) | 128-139 |
Number of pages | 12 |
Journal | Journal of Communication in Healthcare |
Volume | 11 |
Issue number | 2 |
DOIs | |
State | Published - Apr 3 2018 |
Bibliographical note
Funding Information:Disseminating quality information on rare diseases has been a priority for policy makers and health activists. The need for a centralized clearinghouse of rare diseases information was recognized by the National Commission on Rare Diseases in 1989. Supported by the Rare Disease Act passed by the Congress in 2002, the National Institutes of Health (NIH) established the Genetic and Rare Diseases (GARD) Information Center,
Funding Information:
This project was supported by the National Human Genome Research Institute (US) under Award number R21HG007111.
Publisher Copyright:
© 2018, © 2018 Informa UK Limited, trading as Taylor & Francis Group.
Funding
Disseminating quality information on rare diseases has been a priority for policy makers and health activists. The need for a centralized clearinghouse of rare diseases information was recognized by the National Commission on Rare Diseases in 1989. Supported by the Rare Disease Act passed by the Congress in 2002, the National Institutes of Health (NIH) established the Genetic and Rare Diseases (GARD) Information Center, This project was supported by the National Human Genome Research Institute (US) under Award number R21HG007111.
Funders | Funder number |
---|---|
National Institutes of Health (NIH) | |
National Human Genome Research Institute | R21HG007111 |
Keywords
- genetic determinism
- health websites
- information sharing
- patient engagement
- rare diseases
- spirituality
ASJC Scopus subject areas
- Communication
- Health Information Management